Interleukin Antibody

Lecankitug is a humanized monoclonal antibody that targets human interleukin 17A (IL-17A) and interleukin 17F (IL-17F) . By specifically binding to IL-17A and IL-17F, Lecankitug blocks their signaling pathways, exhibiting immunosuppressive and anti-inflammatory actions. It is a promising candidate for research in autoimmune and inflammatory diseases, such as psoriasis and rheumatoid arthritis.